CIC
PCRX icon

Cornercap Investment Counsel’s Pacira BioSciences PCRX Stock Holding History

Cornercap Investment Counsel’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,003
Closed -$1M – 617
2024
Q2 		$1M Sell
35,003
-372
-1% -$10.6K 0.16% 236
2024
Q1 		$1.03M Hold
35,375
– – 0.16% 245
2023
Q4 		$1.19M Buy
35,375
+4,368
+14% +$128K 0.2% 159
2023
Q3 		$951K Buy
+31,007
New +$1.12M 0.17% 221
2019
Q2 		– Sell
-13,195
Closed -$502K – 466
2019
Q1 		$502K Buy
+13,195
New +$515K 0.07% 359

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Cornercap Investment Counsel's PCRX Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 35,003 shares — an estimated $1M sold.

Cornercap Investment Counsel first reported a position in PCRX in Q1 2019 and held it in 5 quarters. The position peaked at $1.19M in Q4 2023. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 35,003 Pacira BioSciences shares in Q3 2024, an estimated $1M.
  • Cornercap Investment Counsel first reported a position in Pacira BioSciences in Q1 2019 and held it in 5 quarters.
  • Cornercap Investment Counsel's Pacira BioSciences position peaked at $1.19M in Q4 2023.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.